According to GuruFocus' list of five-year lows, these guru stocks have reached their five-year lows: Blucora Inc. (BCOR, Financial), SeaChange International Inc. (SEAC, Financial), Harte-Hanks Inc. (HHS, Financial) and Aegerion Pharmaceuticals Inc. (AEGR, Financial).
Blucora reached $4.96
The price of Blucora shares has declined to $4.96, which is only 5.4% above the five-year low of $4.69. It is now 84.4% off the five-year high of $30.12. Blucora is owned by three gurus we are tracking. Among them, two have added to their positions during the past quarter. Two others sold their stakes. Blucora has a market cap of $204.387 million and a P/S ratio of 0.54.
Blucora released its 2015 full-year results with net sales of $117.7 million and net loss of $40.1 million.
Guru Joel Greenblatt (Trades, Portfolio) sold his position in Blucora in the fourth quarter. Mario Gabelli (Trades, Portfolio) reduced his position. He owns 547,670 shares.
President and CEO William J. Ruckelshaus bought 7,230 shares of BCOR stock on Nov. 11, 2015, at the average price of 10.36. Ruckelshaus owns at least 205,009 shares. The price of the stock has decreased by 52.12%. Directors Andrew Miles Snyder, Lance G. Dunn, Elizabeth Huebner and Christopher William Walters and Chief Legal and Admin. Officer Mark A. Finkelstein bought 254,168 shares between them in November.
SeaChange International reached $5.48
The price of SeaChange International shares has declined to $5.48, which is only 8.6% above the five-year low of $5.01. It is now 67.1% off the five-year high of $15.25. SeaChange International is owned by three gurus we are tracking. Among them, one added to his position during the past quarter. One reduced his position.
Seachange International has a market cap of $184.65 million and a P/S ratio of 1.64.
SeaChange International declared its 2015 third fiscal-quarter results with net sales of $28.7 million and net loss of $10.6 million.
Harte-Hanks reached $2.74
The price of Harte-Hanks shares has declined to $2.74, which is only 8.8% above the five-year low of $2.50. It is now 79.5% off the five-year high of $12.22. Harte-Hanks is owned by three gurus we are tracking. Among them, one added to his position, and two reduced their positions. Harte-Hanks has a market cap of $167.872 million and a P/S ratio of 0.34. The trailing 12-month dividend yield of Harte-Hanks stocks is 12.41%.
Harte-Hanks recognized net sales of $495.3 million and net loss of $170.9 million in its 2015 annual results.
Greenblatt reduced his position in Harte-Hanks in the fourth quarter.
Aegerion Pharmaceuticals reached $3.55
The price of Aegerion Pharmaceuticals declined to $3.55, which is only 6.5% above the five-year low of $3.32. It is now 96.7% off the five-year high of $101. Aegerion Pharmaceuticals is owned by three urus we are tracking. Among them, one added to his position during the fourth quarter. The stock was a new buy for the other two gurus.
Aegerion Pharmaceuticals has a market cap of $104.63 million with a P/S ratio of 0.42.
Aegerion Pharmaceuticals announced its 2015 annual results with net loss of $73.3 million and net product sales of $239.9 million.
Go here for the complete list of five-year lows.
